© 2026 Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy

2020-08-14
To prevent the transfusion reaction, leuko-depletion before transfusion is a norm in most of the countries. PuriBlood is committed to improving the blood filtration process with innovative technology. Our products provide better and stable filtration performance, which can remove more than 99.99% of white blood cells and reduce filtration time.
Product features
● In compliance with FDA/CE guidance
● Short filtration time
● High WBC removal
● High RBC recovery
● Minimal volume loss
● Easy to use
For more product and technology details, please write to info@puriblood.com
Booth No. L1318
Look for: Agents/distributors, and blood bank practitioners welcome to consult and collaborate
